Ετικέτες

Παρασκευή 8 Σεπτεμβρίου 2017

Can the extent of heart rate reduction predict the clinical response of infantile hemangiomas to propranolol?

Abstract

Propranolol is the first-line medical treatment of complicated infantile hemangiomas (IH)1. It was suggested that a heart rate (HR) reduction of more than 20% compared to baseline HR might be an early marker of response to propranolol2. We aim to explore the relationship between the extent of HR reduction and clinical response of IH to propranolol.

This article is protected by copyright. All rights reserved.



http://ift.tt/2wPJWXA

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αναζήτηση αυτού του ιστολογίου